Talaris Therapeutics, Inc.
TALS
NASDAQ Global Market2.72
USD
-0.02
- -
Total Valuation
Talaris Therapeutics, Inc. carries a market capitalization of 116.44M, placing it among publicly traded companies globally.
| Market Cap | 116.44M |
| Enterprise Value | N/A |
Stock Price Statistics
Talaris Therapeutics, Inc.'s stock has gained approximately 91.5493% over the past 52 weeks. The 50-day moving average sits at 2.83, while the 200-day moving average is 2.44.
| Beta (5Y) | N/A |
| 52-Week Price Change | 91.5493% |
| 50-Day Moving Average | 2.83 |
| 200-Day Moving Average | 2.44 |
| Average Volume (20 Days) | N/A |
Stock Splits
Talaris Therapeutics, Inc.'s most recent stock split took place on October 20, 2023 with a 10:1 split ratio.
| Last Split Date | 10/20/2023 |
| Split Ratio | 10:1 |